CIA
Capital Impact Advisors Portfolio holdings
AUM
$332M
This Quarter Return
+46.47%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$407M
AUM Growth
+$407M
(+21%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27
Top Buys
| 1 |
Veracyte
VCYT
|
$8.81M |
| 2 |
Twist Bioscience
TWST
|
$8.05M |
| 3 |
Pacific Biosciences
PACB
|
$7.78M |
| 4 |
Editas Medicine
EDIT
|
$7.36M |
| 5 |
Intellia Therapeutics
NTLA
|
$5.98M |
Top Sells
| 1 |
Amazon
AMZN
|
$11.7M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$8.84M |
| 3 |
Arrowhead Research
ARWR
|
$6.91M |
| 4 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$6.86M |
| 5 |
Tesla
TSLA
|
$6.35M |
Sector Composition
| 1 | Healthcare | 45.15% |
| 2 | Technology | 24.29% |
| 3 | Communication Services | 9.57% |
| 4 | Consumer Discretionary | 5.1% |
| 5 | Financials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Natera
NTRA
$23.1B
| $4.98M | 1.22% |
50,000
-20,000
| -29% | -$1.99M |
|
|
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.85M | 1.19% |
+27,679
| New | +$4.85M |
|
28
GeoPark
GPRK
$340M
| $4.68M | 1.15% |
13,042
-11,309
| -46% | -$4.06M |
|
29
Corcept Therapeutics
CORT
$7.35B
| $4.64M | 1.14% |
177,300
| – | – |
|
30
NVIDIA
NVDA
$4.24T
| $4.59M | 1.13% |
8,783
+2,000
| +29% | +$1.04M |
|
31
Fastly
FSLY
$1.12B
| $4.37M | 1.07% |
+50,000
| New | +$4.37M |
|
32
CrowdStrike
CRWD
$106B
| $4.34M | 1.07% |
20,500
-5,500
| -21% | -$1.16M |
|
33
Datadog
DDOG
$47.7B
| $4.33M | 1.06% |
44,000
+20,000
| +83% | +$1.97M |
|
|
OTRK
34
DELISTED
Ontrak
OTRK
| $4.25M | 1.04% |
68,800
| – | – |
|
|
35
Tesla
TSLA
$1.08T
| $4.23M | 1.04% |
6,000
-9,000
| -60% | -$6.35M |
|
36
Ameresco
AMRC
$1.34B
| $4.22M | 1.04% |
80,792
| – | – |
|
|
NIU
37
Niu Technologies
NIU
$341M
| $4.17M | 1.02% |
148,800
| – | – |
|
38
Omnicell
OMCL
$1.5B
| $4.07M | 1% |
33,938
| – | – |
|
39
GrowGeneration
GRWG
$102M
| $4.02M | 0.99% |
+100,000
| New | +$4.02M |
|
40
Blackrock
BLK
$175B
| $3.93M | 0.96% |
5,440
| – | – |
|
41
Okta
OKTA
$16.4B
| $3.81M | 0.94% |
15,000
+7,500
| +100% | +$1.91M |
|
42
Iovance Biotherapeutics
IOVA
$807M
| $3.71M | 0.91% |
80,000
| – | – |
|
43
Zynex
ZYXI
$49.7M
| $3.71M | 0.91% |
275,534
+79,800
| +41% | +$1.07M |
|
44
Vicor
VICR
$2.3B
| $3.62M | 0.89% |
39,282
| – | – |
|
45
Ionis Pharmaceuticals
IONS
$6.79B
| $3.6M | 0.88% |
63,707
| – | – |
|
46
Freshpet
FRPT
$2.72B
| $3.55M | 0.87% |
25,000
| – | – |
|
47
Ultragenyx Pharmaceutical
RARE
$2.89B
| $3.54M | 0.87% |
25,582
-25,000
| -49% | -$3.46M |
|
48
VeriSign
VRSN
$25.5B
| $3.51M | 0.86% |
16,212
| – | – |
|
49
Insperity
NSP
$2.08B
| $3.44M | 0.84% |
42,216
| – | – |
|
50
ResMed
RMD
$40.2B
| $3.43M | 0.84% |
16,125
| – | – |
|